SCHEMBL4512438

SCHEMBL4512438

CC(=O)c1c(C)[nH]c2ccccc2c1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.61
NPC1 O15118 4/20 0.61
JAK2 O60674 1/20 0.61
PAX8 Q06710 1/20 0.61
NR4A2 P43354 1/20 0.57
ALDH1A1 P00352 5/20 0.55
KMT2A Q03164 5/20 0.55
LMNA P02545 3/20 0.55
KDM4E B2RXH2 3/20 0.55
MITF O75030 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
HTT P42858 3/20 0.54
GAA P10253 3/20 0.52
GLA P06280 1/20 0.52
HPGD P15428 1/20 0.52
ATM Q13315 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HTR3E A5X5Y0 1/20 0.51
HTR3B O95264 1/20 0.51
HTR3A P46098 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705595 0.87 NR4A2 (0.67) RAB9ANPC1NR4A2ALDH1A1KMT2A
SCHEMBL10513594 0.86 RAB9A (0.65) RAB9ANPC1JAK2PAX8NR4A2
SCHEMBL16400953 0.82 NR4A2 (0.79) RAB9ANPC1JAK2PAX8NR4A2
SCHEMBL25551021 0.81 KDM4E (0.58) RAB9ANPC1JAK2PAX8ALDH1A1
SCHEMBL19846945 0.80 KDM4E (0.58) RAB9ANPC1JAK2PAX8NR4A2
SCHEMBL27854856 0.78 NR4A2 (0.69) RAB9ANPC1NR4A2ALDH1A1KMT2A
SCHEMBL1548860 0.77 MAPT (0.53) RAB9ANPC1JAK2PAX8NR4A2
SCHEMBL570154 0.77 NR4A2 (0.67) RAB9ANPC1JAK2PAX8NR4A2
SCHEMBL29799256 0.77 HTT (0.59) RAB9ANPC1JAK2PAX8NR4A2
SCHEMBL5114407 0.77 HTT (0.59) RAB9ANPC1JAK2PAX8NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed
EP-1857104-A1 USE OF CINNAMOYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143368-A1 Use of Cinnamoyl Compound COL2A1, COL1A1, SMAD2 RAB9A 4027/4885NPC1 462/4885JAK2 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.